Results: 1-5 |
Results: 5

Authors: Hurenkamp, GJB Grundmeijer, HGLM Van der Ende, A Tytgat, GNJ Assendelft, WJJ Van der Hulst, RWM
Citation: Gjb. Hurenkamp et al., Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study, ALIM PHARM, 15(7), 2001, pp. 1047-1054

Authors: Hurenkamp, GJB van der Ende, A Grundmeijer, HGLM Tytgat, GNJ Van der Hulst, RWM
Citation: Gjb. Hurenkamp et al., Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease, ALIM PHARM, 14(8), 2000, pp. 1065-1070

Authors: Van den Brink, GR Tytgat, KMAJ Van der Hulst, RWM Van der Loos, CM Einerhand, AWC Buller, HA Dekker, J
Citation: Gr. Van Den Brink et al., H pylori colocalises with MUC5AC in the human stomach, GUT, 46(5), 2000, pp. 601-607

Authors: Van der Hulst, RWM Lamouliatte, H Megraud, F Pounder, RE Stoltes, M Vaira, D Williams, M Tytgat, GNJ
Citation: Rwm. Van Der Hulst et al., Laser assisted ratio analyser C-13-urea breath testing, for the detection of H-pylori: a prospective diagnostic European multicentre study, ALIM PHARM, 13(9), 1999, pp. 1171-1177

Authors: Houben, MHMG Hensen, EF Rauws, EAJ Van der Hulst, RWM Van't Hoff, BWM Van der Ende, A Ten Kate, FJW Tytgat, GNJ
Citation: Mhmg. Houben et al., Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains, ALIM PHARM, 13(7), 1999, pp. 883-889
Risultati: 1-5 |